Autism Spectrum Disorder: A Neuro-Immunometabolic Hypothesis of the Developmental Origins.
autism spectrum disorder
genomics
information theory
multi-scale modeling
Journal
Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988
Informations de publication
Date de publication:
26 Jun 2023
26 Jun 2023
Historique:
received:
09
05
2023
revised:
15
06
2023
accepted:
21
06
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Fetal neuroinflammation and prenatal stress (PS) may contribute to lifelong neurological disabilities. Astrocytes and microglia, among the brain's non-neuronal "glia" cell populations, play a pivotal role in neurodevelopment and predisposition to and initiation of disease throughout lifespan. One of the most common neurodevelopmental disorders manifesting between 1-4 years of age is the autism spectrum disorder (ASD). A pathological glial-neuronal interplay is thought to increase the risk for clinical manifestation of ASD in at-risk children, but the mechanisms remain poorly understood, and integrative, multi-scale models are needed. We propose a model that integrates the data across the scales of physiological organization, from genome to phenotype, and provides a foundation to explain the disparate findings on the genomic level. We hypothesize that via gene-environment interactions, fetal neuroinflammation and PS may reprogram glial immunometabolic phenotypes that impact neurodevelopment and neurobehavior. Drawing on genomic data from the recently published series of ovine and rodent glial transcriptome analyses with fetuses exposed to neuroinflammation or PS, we conducted an analysis on the Simons Foundation Autism Research Initiative (SFARI) Gene database. We confirmed 21 gene hits. Using unsupervised statistical network analysis, we then identified six clusters of probable protein-protein interactions mapping onto the immunometabolic and stress response networks and epigenetic memory. These findings support our hypothesis. We discuss the implications for ASD etiology, early detection, and novel therapeutic approaches. We conclude with delineation of the next steps to verify our model on the individual gene level in an assumption-free manner. The proposed model is of interest for the multidisciplinary community of stakeholders engaged in ASD research, the development of novel pharmacological and non-pharmacological treatments, early prevention, and detection as well as for policy makers.
Identifiants
pubmed: 37508346
pii: biology12070914
doi: 10.3390/biology12070914
pmc: PMC10375982
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cell Mol Life Sci. 2018 Sep;75(18):3353-3369
pubmed: 29974127
J Neurosci. 2013 Jan 30;33(5):2039-47
pubmed: 23365241
Arch Gynecol Obstet. 2020 Feb;301(2):405-414
pubmed: 31781889
J Neuropathol Exp Neurol. 2017 Apr 1;76(4):332-334
pubmed: 28340120
J Mol Neurosci. 2013 May;50(1):33-57
pubmed: 22836882
Biomed Res Int. 2014;2014:718769
pubmed: 24757672
Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):E3687-95
pubmed: 23236169
J Biol Chem. 2008 Feb 1;283(5):2631-43
pubmed: 18057005
Clin Epigenetics. 2022 Jul 14;14(1):87
pubmed: 35836289
PLoS One. 2017 Dec 14;12(12):e0189518
pubmed: 29240833
Science. 2011 Sep 9;333(6048):1456-8
pubmed: 21778362
Front Neurosci. 2017 Jan 20;10:609
pubmed: 28163670
Transl Psychiatry. 2014 Oct 14;4:e466
pubmed: 25313509
J Neurosci. 2016 Feb 10;36(6):2027-43
pubmed: 26865625
J Cell Mol Med. 2019 May;23(5):3214-3223
pubmed: 30809946
Front Cell Neurosci. 2015 Aug 04;9:294
pubmed: 26300730
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5169-74
pubmed: 23487789
Sci Rep. 2016 Oct 12;6:35135
pubmed: 27731403
Neurosci Biobehav Rev. 2020 Oct;117:165-183
pubmed: 29859198
Nat Rev Neurol. 2021 Sep;17(9):564-579
pubmed: 34341569
Nat Commun. 2017 May 02;8:15132
pubmed: 28462931
J Neuroinflammation. 2013 Apr 09;10:46
pubmed: 23570274
Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9639-44
pubmed: 24979775
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15220-5
pubmed: 25288765
Front Neurosci. 2016 Apr 14;10:142
pubmed: 27147943
J Neuroinflammation. 2016 May 10;13(1):103
pubmed: 27165310
Science. 2016 May 6;352(6286):712-716
pubmed: 27033548
Sci Rep. 2017 Mar 10;7:44155
pubmed: 28281572
PLoS One. 2009 Dec 07;4(12):e8161
pubmed: 19997592
Front Integr Neurosci. 2013 Jul 15;7:53
pubmed: 23874274
Brain. 2008 Sep;131(Pt 9):2464-78
pubmed: 18550622
Brain Dev. 2013 Aug;35(7):607-13
pubmed: 23141185
Am J Psychiatry. 2010 Dec;167(12):1508-17
pubmed: 20952458
Cell Stress. 2018 Oct;2(10):246-252
pubmed: 30417169
Neuron. 2017 Apr 19;94(2):278-293.e9
pubmed: 28426964
Nat Neurosci. 2014 Jan;17(1):131-43
pubmed: 24316888
Neuropathology. 2016 Feb;36(1):39-49
pubmed: 26250788
EMBO Mol Med. 2015 Dec 15;8(1):25-38
pubmed: 26671989
Mol Cell. 2016 Jun 2;62(5):695-711
pubmed: 27259202
Neurosci Biobehav Rev. 2020 Mar;110:77-91
pubmed: 30470595
Semin Nephrol. 2013 Nov;33(6):479-92
pubmed: 24161035
J Neural Transm (Vienna). 2009 Jun;116(6):689-97
pubmed: 19280114
Learn Mem. 2012 Sep 14;19(10):449-52
pubmed: 22984282
Mol Autism. 2014 Jan 10;5(1):1
pubmed: 24410847
Exp Biol Med (Maywood). 2010 Oct;235(10):1163-7
pubmed: 20881320
Nature. 2015 Mar 12;519(7542):223-8
pubmed: 25533962
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):495-500
pubmed: 11756680
Bioinformatics. 2022 Jan 27;38(4):1075-1086
pubmed: 34788368
J Neuroinflammation. 2016 Nov 24;13(1):297
pubmed: 27881137
Arch Intern Med. 1993 Sep 27;153(18):2093-101
pubmed: 8379800
BMC Psychiatry. 2019 Apr 15;19(1):113
pubmed: 30987620
Annu Rev Immunol. 2012;30:313-35
pubmed: 22224768
Mol Syst Biol. 2014 Dec 30;10:774
pubmed: 25549968
J Cell Physiol. 2012 Sep;227(9):3169-77
pubmed: 22261928
Front Neuroendocrinol. 2011 Aug;32(3):265-86
pubmed: 21144857
Nat Commun. 2017 Oct 30;8(1):1193
pubmed: 29084956
Brain Behav Immun. 2017 Feb;60:361-368
pubmed: 27989860
J Cereb Blood Flow Metab. 2011 May;31(5):1187-95
pubmed: 21364605
Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):E1738-46
pubmed: 26884166
Nat Neurosci. 2016 Jan;19(1):102-10
pubmed: 26656643
Cell. 2018 Jan 11;172(1-2):22-40
pubmed: 29328913
Pharmacol Res. 2019 Feb;140:21-32
pubmed: 30423430
Int J Mol Cell Med. 2017 Summer;6(3):148-155
pubmed: 29682486
Trends Genet. 2014 Jun;30(6):230-6
pubmed: 24780085
ACS Omega. 2021 Sep 04;6(37):24128-24138
pubmed: 34568691
Front Cell Neurosci. 2018 Jun 07;12:158
pubmed: 29930500
Reprod Sci. 2011 Feb;18(2):172-9
pubmed: 20959640
Cereb Cortex. 2016 May;26(5):2299-2310
pubmed: 26679195
BMC Genomics. 2020 Nov 18;21(Suppl 10):615
pubmed: 33208103
Front Neurol. 2014 Aug 11;5:150
pubmed: 25157238
Prog Neurobiol. 2017 Sep;156:164-188
pubmed: 28576664
Sci Rep. 2017 Sep 6;7(1):10645
pubmed: 28878260
JAMA Psychiatry. 2019 Jun 1;76(6):594-602
pubmed: 30840048
Neuropsychopharmacology. 2012 Nov;37(12):2671-83
pubmed: 22828749
Neuron. 2012 May 24;74(4):691-705
pubmed: 22632727
Front Cell Neurosci. 2013 Mar 26;7:28
pubmed: 23533374
Curr Neuropharmacol. 2022;20(1):94-106
pubmed: 33550974
eNeuro. 2020 Dec 17;7(6):
pubmed: 33199411
Brain Behav Immun. 2016 Oct;57:125-133
pubmed: 26979869